Dr. Jo Howe and Professor Ian Maidment from Aston Pharmacy School have won funding for a new project to develop new ways to ...

New drug approved for treating chronic schizophrenia with fewer side effects. Could be beneficial for Black community.

Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...

Quetiapine is an antipsychotic medication that people who live with schizophrenia or bipolar rely on. Pharmacists say they ...

Purpose: The association of antipsychotic and antidepressant drugs with Q-T interval prolongation is reviewed. Summary: Prolongation of the Q-T interval can be of particular concern to ...

In diabetes, “brittle diabetic” refers to a patient for whom the correct dose of insulin is hard to find. The analogies with ...

A Peoria nursing home received nearly $30,000 in fines last year from the Illinois Department of Public Health for failing to prevent residents from wandering off the property, not properly providing ...

Quetiapine is an antipsychotic medication that people who live with schizophrenia or bipolar rely on. There is currently a nationwide shortage of the drug. According to the Therapeutic Goods ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Ecumen North Branch has been named “Best Nursing Home” by U.S. News & World Report for their short-term rehabilitation services. To be considered for this recognition, a senior living community ...

Results support advancing LB-102 to Phase 3 clinical development in schizophrenia . NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) ...

Cambridge Cognition announced the use of its ‘CANTAB’ cognitive assessment product in two phase three clinical trials conducted by Bristol Myers Squibb for ‘Cobenfy’, a newly FDA-approved treatment ...